Regulators in France, Germany, Belgium and Luxembourg are suspending the marketing approval of 25 generic drugs due to concerns over the quality of data from clinical trials conducted by India's GVK Biosciences, French watchdog ANSM said on Friday.
GVK Biosciences
Breaking News
Subscribe to VCpost newsletter
Most Popular
- Where's My Child Tax Credit 2024: When to Receive My Money After April 15 Tax Filing Deadline?
- SSDI Payment April 2024: Who Will Receive Social Security Benefits Today?
- Indiana Children's Museum Reportedly Exposed Total Solar Eclipse Watchers to Measles
- How to Get IRS Unclaimed Tax Refunds: Here's What to Do If You Think You Have Pending Payments
- Kroger and Albertsons to Sell off 166 Stores in Effort to Gain Approval for Their $25 Billion Merger
- Philippines Wants US, Japan to Fund Freight Railway Project After It Drops Funding Talks With China
- Student Loan Forgiveness Processing for This Group of Borrowers Will Stop Next Week
- Celebrity Designer Nancy Gonzalez Jailed for Smuggling Crocodile, Python Handbags